Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaylene J Simpson

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|August 18, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.
Nature Cell Biology|December 22, 2023
Quantitative subcellular reconstruction reveals a lipid mediated inter-organelle biogenesis networkRichard G Lee, Danielle L Rudler, Samuel A Raven, et al.
British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
British Journal of Cancer|October 25, 2024
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Science Advances|September 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restrictionKenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, et al.
Cell Death and Differentiation|July 13, 2022
Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysisIsabella Y Kong, Stephanie Trezise, Amanda Light, et al.
Science Signaling|October 5, 2017
Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodelingSteven P Williams, Adam F Odell, Tara Karnezis, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|August 18, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.
Nature Cell Biology|December 22, 2023
Quantitative subcellular reconstruction reveals a lipid mediated inter-organelle biogenesis networkRichard G Lee, Danielle L Rudler, Samuel A Raven, et al.
British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
British Journal of Cancer|October 25, 2024
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Science Advances|September 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restrictionKenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, et al.
Cell Death and Differentiation|July 13, 2022
Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysisIsabella Y Kong, Stephanie Trezise, Amanda Light, et al.
Science Signaling|October 5, 2017
Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodelingSteven P Williams, Adam F Odell, Tara Karnezis, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Pageof 12